<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Abstract Background To study the effects of z-guggulsterone on gastric" exact="cancer" post="cell apoptosis and the mechanism related. Materials and Methods"/>
 <result pre="deadly malignancy and the main cause of cancer-related deaths, gastric" exact="cancer" post="is becoming a severe worldwide health problem. Until now,"/>
 <result pre="is becoming a severe worldwide health problem. Until now, gastric" exact="cancer" post="still has a poor prognosis in spite of improvements"/>
 <result pre="following surgical excision is the most popular method for gastric" exact="cancer" post="therapy, but chemotherapy options are limited due to the"/>
 <result pre="due to the fact that these treatments kill not only" exact="cancer" post="cells but also normal cells by inducing toxicity and"/>
 <result pre="carried out studies to develop safe reagents that can target" exact="cancer" post="cells and induce little damage to normal cells. Naturally"/>
 <result pre="normal cells. Naturally occurring compounds have the potential to treat" exact="cancer" post="patients [3]. The plant steroid z-guggulsterone, obtained from Commiphora"/>
 <result pre="antagonist to treat obesity, lipid metabolism dysfunction, hypothyroidism, inflammation, and" exact="arthritis" post="[4]. Z-guggulsterone induces apoptosis in various cancer cell types"/>
 <result pre="hypothyroidism, inflammation, and arthritis [4]. Z-guggulsterone induces apoptosis in various" exact="cancer" post="cell types such as prostate cancer, acute myelocytic leukemia,"/>
 <result pre="Z-guggulsterone induces apoptosis in various cancer cell types such as" exact="prostate cancer," post="acute myelocytic leukemia, colon cancer, liver cancer, glioma, pancreatic"/>
 <result pre="cancer cell types such as prostate cancer, acute myelocytic leukemia," exact="colon cancer," post="liver cancer, glioma, pancreatic cancer, esophageal cancer, and gastric"/>
 <result pre="types such as prostate cancer, acute myelocytic leukemia, colon cancer," exact="liver cancer," post="glioma, pancreatic cancer, esophageal cancer, and gastric cancer [5â€&quot;13]."/>
 <result pre="prostate cancer, acute myelocytic leukemia, colon cancer, liver cancer, glioma," exact="pancreatic cancer," post="esophageal cancer, and gastric cancer [5â€&quot;13]. While several studies"/>
 <result pre="acute myelocytic leukemia, colon cancer, liver cancer, glioma, pancreatic cancer," exact="esophageal cancer," post="and gastric cancer [5â€&quot;13]. While several studies have demonstrated"/>
 <result pre="cancer, liver cancer, glioma, pancreatic cancer, esophageal cancer, and gastric" exact="cancer" post="[5â€&quot;13]. While several studies have demonstrated the antitumor activities"/>
 <result pre="Culture Human gastric normal cell line GES-1 and human gastric" exact="cancer" post="cell lines SGC-7901 were provided by the Cell Bank"/>
 <result pre="Annexin V/Propidium Iodide (PI) Staining and Hoechst 33258 Staining Gastric" exact="cancer" post="cells were plated in 6-well plates (2â€‰Ã—â€‰105 cells/well) and"/>
 <result pre="chemiluminescence reagent (Thermo Fisher, USA). 2.5. Caspase-3 Activity Assay Gastric" exact="cancer" post="cells were plated in 6-well plates (2â€‰Ã—â€‰105 cells/well) and"/>
 <result pre="caspase-3 following the manufacturer's instructions. 2.6. Determination of Cytokines Gastric" exact="cancer" post="cells were plated in 6-well plates (2â€‰Ã—â€‰105 cells/well) and"/>
 <result pre="determine the contents of VEGF, TNF-Î±, and TGF-Î²1 in gastric" exact="cancer" post="cells following the manufacturer's instructions. 2.7. Statistical Analysis For"/>
 <result pre="Gastric Cancer Cells We analyzed FXR expression level in gastric" exact="cancer" post="cells. The expression of FXR was significantly higher in"/>
 <result pre="is a classic downstream molecular of FXR during metabolism and" exact="cancer" post="progression. We then analyzed the expression of SHP in"/>
 <result pre="progression. We then analyzed the expression of SHP in gastric" exact="cancer" post="cells. The result showed a higher expression of SHP"/>
 <result pre="1(a)). This difference demonstrates a higher FXR signaling in gastric" exact="cancer" post="cells. 3.2. Z-Guggulsterone Exhibited Potent Antitumor Activity in SGC-7901"/>
 <result pre="Apoptosis in SGC-7901 Cells To understand whether z-guggulsterone induces gastric" exact="cancer" post="cell apoptosis, we performed Annexin V/PI staining following treatment"/>
 <result pre="75â€‰ÂµM z-guggulsterone (p &amp;gt; 0.05) (Figure 4(b)). 4. Discussion Gastric" exact="cancer" post="causes increasing cancer-related deaths throughout the world. The chemotherapy"/>
 <result pre="deaths throughout the world. The chemotherapy used to treat gastric" exact="cancer" post="kills not only cancer cells but also normal cells"/>
 <result pre="The chemotherapy used to treat gastric cancer kills not only" exact="cancer" post="cells but also normal cells by inducing toxicity and"/>
 <result pre="has been investigated thoroughly to cure numerous malignancies including gastric" exact="cancer" post="[4]. Z-guggulsterone has been investigated to function as an"/>
 <result pre="an antagonist of FXR to inhibit cell survival and induce" exact="cancer" post="cell death [6, 9]. However, the role of z-guggulsterone"/>
 <result pre="the role of z-guggulsterone in the cell apoptosis of gastric" exact="cancer" post="is not completely clear. Our results indicated that the"/>
 <result pre="FXR and its downstream target SHP is higher in SGC-7901" exact="cancer" post="cells compared with GES-1 normal gastric cells. Z-guggulsterone greatly"/>
 <result pre="was involved in the mitochondrial apoptotic signaling pathway to prevent" exact="cancer" post="growth [9, 15, 16]. We also found that z-guggulsterone"/>
 <result pre="[17]. The cytokines TGF-Î² and TNF-Î± regulate apoptosis in various" exact="cancer" post="cells and are associated with carcinogenesis [18]. VEGF is"/>
 <result pre="is a characteristic factor for angiogenesis and cell viability during" exact="cancer" post="progression [19]. Our results indicated that z-guggulsterone dose-dependently raised"/>
 <result pre="and reduced the levels of TGF-Î²1 and VEGF in gastric" exact="cancer" post="cells. In the future, we would like to make"/>
 <result pre="signaling, MAPK signaling, EGFR, and Jak2-STAT3 signaling pathways in various" exact="cancer" post="cells [15, 16, 20]. However, the mechanism underlying z-guggulsterone"/>
 <result pre="20]. However, the mechanism underlying z-guggulsterone anticancer effects in gastric" exact="cancer" post="cells is not completely understood. Here, we showed that"/>
 <result pre="understood. Here, we showed that z-guggulsterone exerted cytotoxicity on gastric" exact="cancer" post="cells through inhibition of FXR signaling. Moreover, the mitochondrial"/>
 <result pre="treatment. Thus, our findings showed that when compared with gastric" exact="cancer" post="cells, normal gastric mucosa cells were less affected by"/>
 <result pre="were less affected by z-guggulsterone, similar to results obtained in" exact="colon cancer" post="[9], liver cancer [10], and others. 5. Conclusions We"/>
 <result pre="less affected by z-guggulsterone, similar to results obtained in colon" exact="cancer" post="[9], liver cancer [10], and others. 5. Conclusions We"/>
 <result pre="by z-guggulsterone, similar to results obtained in colon cancer [9]," exact="liver cancer" post="[10], and others. 5. Conclusions We demonstrated that FXR"/>
 <result pre="z-guggulsterone, similar to results obtained in colon cancer [9], liver" exact="cancer" post="[10], and others. 5. Conclusions We demonstrated that FXR"/>
 <result pre="Conclusions We demonstrated that FXR signaling antagonist z-guggulsterone reduced gastric" exact="cancer" post="cell viability through inhibiting cell proliferation, decreasing intrinsic mitochondrial"/>
 <result pre="contributed to this work. References 1FerroA.PeleteiroB.MalvezziM.et al.Worldwide trends in gastric" exact="cancer" post="mortality (1980â€&quot;2011), with predictions to 2015, and incidence by"/>
 <result pre="of Cancer20145071330134410.1016/j.ejca.2014.01.02924650579 2WangS. M.ZhengR. S.ZhangS. W.et al.Epidemiological characteristics of gastric" exact="cancer" post="in China, 2015Zhonghua Liu Xing Bing Xue Za Zhi"/>
 <result pre="Zhi = Zhonghua Liuxingbingxue Zazhi201940121517152110.3760/cma.j.issn.0254-6450.2019.12.00332062908 3YeungK. S.GubiliJ.MaoJ. J.Herb-drug interactions in" exact="cancer" post="careOncology2018321051652030334243 4AhmadM. A.MujeebM.AkhtarM.et al.Guggulipid: a promising multi-purpose herbal medicinal"/>
 <result pre="and in vivoMolecular Cancer Therapeutics20087117118010.1158/1535-7163.mct-07-049118202020 6SinghS. V.ChoiS.ZengY.HahmE.-R.XiaoD.Guggulsterone-induced apoptosis in human" exact="prostate cancer" post="cells is caused by reactive oxygen intermediate dependent activation"/>
 <result pre="in vivoMolecular Cancer Therapeutics20087117118010.1158/1535-7163.mct-07-049118202020 6SinghS. V.ChoiS.ZengY.HahmE.-R.XiaoD.Guggulsterone-induced apoptosis in human prostate" exact="cancer" post="cells is caused by reactive oxygen intermediate dependent activation"/>
 <result pre="al.Guggulsterone inhibits angiogenesis by blocking STAT3 and VEGF expression in" exact="colon cancer" post="cellsOncology Reports20082061321132710.3892/or_0000014719020709 9AnM. J.CheonJ. H.KimS. W.KimE. S.KimT. I.KimW. H.Guggulsterone"/>
 <result pre="inhibits angiogenesis by blocking STAT3 and VEGF expression in colon" exact="cancer" post="cellsOncology Reports20082061321132710.3892/or_0000014719020709 9AnM. J.CheonJ. H.KimS. W.KimE. S.KimT. I.KimW. H.Guggulsterone"/>
 <result pre="9AnM. J.CheonJ. H.KimS. W.KimE. S.KimT. I.KimW. H.Guggulsterone induces apoptosis in" exact="colon cancer" post="cells and inhibits tumor growth in murine colorectal cancer"/>
 <result pre="J.CheonJ. H.KimS. W.KimE. S.KimT. I.KimW. H.Guggulsterone induces apoptosis in colon" exact="cancer" post="cells and inhibits tumor growth in murine colorectal cancer"/>
 <result pre="in colon cancer cells and inhibits tumor growth in murine" exact="colorectal cancer" post="xenograftsCancer Letters200927919310010.1016/j.canlet.2009.01.02619232820 10ShiJ.-J.JiaX. L.LiM.et al.Guggulsterone induces apoptosis of human"/>
 <result pre="colon cancer cells and inhibits tumor growth in murine colorectal" exact="cancer" post="xenograftsCancer Letters200927919310010.1016/j.canlet.2009.01.02619232820 10ShiJ.-J.JiaX. L.LiM.et al.Guggulsterone induces apoptosis of human"/>
 <result pre="cancer xenograftsCancer Letters200927919310010.1016/j.canlet.2009.01.02619232820 10ShiJ.-J.JiaX. L.LiM.et al.Guggulsterone induces apoptosis of human" exact="hepatocellular carcinoma" post="cells through intrinsic mitochondrial pathwayWorld Journal of Gastroenterology20152147132771328710.3748/wjg.v21.i47.1327726715810 11DixitD.GhildiyalR.AntoN."/>
 <result pre="Letters2013336234735810.1016/j.canlet.2013.03.02523548480 12LeeJ. Y.LeeK. T.LeeJ. K.et al.Farnesoid X receptor, overexpressed in" exact="pancreatic cancer" post="with lymph node metastasis promotes cell migration and invasionBritish"/>
 <result pre="12LeeJ. Y.LeeK. T.LeeJ. K.et al.Farnesoid X receptor, overexpressed in pancreatic" exact="cancer" post="with lymph node metastasis promotes cell migration and invasionBritish"/>
 <result pre="invasionBritish Journal of Cancer201110461027103710.1038/bjc.2011.3721364590 13GuanB.LiH.YangZ.HoqueA.XuX.Inhibition of farnesoid X receptor controls" exact="esophageal cancer" post="cell growth in vitro and in nude mouse xenograftsCancer201311971321132910.1002/cncr.2791023280144"/>
 <result pre="Journal of Cancer201110461027103710.1038/bjc.2011.3721364590 13GuanB.LiH.YangZ.HoqueA.XuX.Inhibition of farnesoid X receptor controls esophageal" exact="cancer" post="cell growth in vitro and in nude mouse xenograftsCancer201311971321132910.1002/cncr.2791023280144"/>
</results>
